AnaptysBio Inc. logo

AnaptysBio Inc.

ANAB | NASDAQ
Chart Builder DCF Calculator
$47.43
-$0.85 (-1.76%)
Nov 2, 2026, 12:41 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
49.61M -145.23M -163.62M -128.72M -57.8M -19.93M
Depreciation & Amortization
2.42M 2.4M 2.38M 2.34M 2.09M 559K
Stock-Based Compensation
36.07M 34.05M 33.21M 27.36M 15.35M 11.5M
Other Working Capital
-313K 1.43M -5.83M -2.32M -1.87M -6.77M
Other Non-Cash Items
12.31M 39.77M 7.56M 18.6M 1.93M 487K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-80.73M -66.33M -324K 6.84M -7.49M -6.77M
Operating Cash Flow
19.7M -135.34M -120.8M -73.59M -45.92M -14.16M
Capital Expenditures
-87K -358K -807K -358K -1.37M -569K
Cash Acquisitions
n/a n/a n/a 394.49M n/a n/a
Purchase of Investments
-196.41M -380.38M -303.92M -802.5M -118.66M -194.93M
Sales Maturities Of Investments
424.53M 476.13M 449.48M 408.02M 158.85M 289.97M
Other Investing Acitivies
n/a n/a n/a -394.49M 15K n/a
Investing Cash Flow
228.03M 95.4M 144.75M -394.85M 38.84M 94.48M
Debt Repayment
-76.8M 34.77M -11.73M n/a n/a -1.38M
Common Stock Repurchased
-68.63M -456K -50M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.45M -8.1M -43K 32.19M 249.75M n/a
Financial Cash Flow
-132.61M 127.05M -59.3M 44.02M 252.3M -879K
Net Cash Flow
115.12M 87.12M -35.34M -424.42M 245.21M 79.44M
Free Cash Flow
19.61M -135.7M -121.61M -73.95M -47.29M -14.73M
Adj. Free Cash Flow
-16.46M -169.74M -154.81M -101.31M -62.63M -26.23M
Maintenance CapEx
n/a n/a n/a -358K -1.37M n/a
Growth CapEx
-87K -358K -807K n/a n/a -569K
Owner Earnings
19.7M -135.34M -120.8M -73.95M -47.29M -14.16M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.